- US12611395utility2026Use of Carbamate Compound for Preventing or Treating Trigeminal Neuralgia0 cites
- US12599585utility2026Use of [(1r)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] Carbamate in Combination Therapy0 cites
- US12409164utility2025Orally Disintegrated Tablet Comprising Carbamate Compound0 cites
- US12384743utility2025Compositions Comprising (r)-2-amino-3-phenylpropyl Carbamate and Uses Thereof0 cites
- US12331035utility2025Bicyclic Compound and Use Thereof0 cites
- US12226399utility2025Oral Aqueous Suspension Formulation Comprising Carbamate Compound0 cites
- US12209059utility2025Treatment of Sleep-wake Disorders0 cites
- US12201601utility2025Treatment for Obesity0 cites
- US12162821utility2024Treatment of Cataplexy0 cites
- US12145914utility2024Compound Having Oxadiazole and Pharmaceutical Composition Containing the Same0 cites
- US12070447utility2024Parenteral Liquid Preparation Comprising Carbamate Compound0 cites
- US12070448utility2024Use of Carbamate Compound for Prevention, Alleviation or Treatment of Status Epilepticus0 cites
- US12037338utility2024Imidazopyrimidine and Imidazotriazine Derivative, and Pharmaceutical Composition Comprising the Same0 cites
- US11753368utility2023Treatment of Sleep-wake Disorders0 cites
- US11725001utility2023Bicyclic Compound and Use Thereof0 cites
- US11717509utility2023Blend Containing Carbamate Compound for Prevention, Mitigation, or Treatment of Schizophrenia0 cites
- US11713292utility2023Treatment of Cataplexy0 cites
- US11666554utility2023Use of a Carbamate Compound to Prevent, Alleviate or Treat Visceralgia or Pain Arising from Visceral Disease0 cites
- US11654133utility2023Use of [(1r)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] Carbamate in Combination Therapy0 cites
Page 1 of 2Next →